Published on
July 7, 2022
- 17:00 GMT
Creating a better clinical development strategy for rare diseases through AI innovation
Volv's AI tool inClude helps identify the target patient population among both diagnosed patients and importantly, undiagnosed people living with disease. LAUSANNE, VAUD, SWITZERLAND, July 7, 2022 /EINPresswire.com/ -- Rare disease drug developers …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
